Background-The sympathetic nervous system and proinflammatory cytokines are believed to play key roles in the pathophysiology of congestive heart failure. To evaluate a possible relationship between these neurohormonal systems, we studied the effects of chronic ␤-adrenergic stimulation on the myocardial and systemic elaboration of tumor necrosis factor (TNF)-␣, interleukin (IL)-1␤, and IL-6. Methods and Results-Male rats received either L-isoproterenol (2.4 mg ⅐ kg Ϫ1 ⅐ d
C hronic activation of the adrenergic nervous system (ANS) in heart failure (HF) results in detrimental myocardial effects, including cardiac myocyte injury and apoptosis, altered signal transduction and cell function, and hypertrophy. 1 These maladaptive changes ultimately cause progressive myocardial remodeling and dysfunction, and advancement of the HF phenotype. Along with ANS activation, HF is characterized by increased local and systemic elaboration of inflammatory cytokines such as tumor necrosis factor (TNF)-␣, interleukin (IL)-1␤, and IL-6. [2] [3] [4] Although their precise role is unclear, inflammatory cytokines induce myocardial effects in vitro that recapitulate the HF phenotype, including myocyte apoptosis 5 and hypertrophy, 6 extracellular matrix alterations, 3 and contractile depression. 3, 7 Despite evidence implicating both adrenergic activation and inflammatory cytokines in the pathogenesis of HF, the important hypothesis that ANS activation serves as a stimulus for myocardial cytokine expression remains largely unexplored. Accordingly, we investigated the influence of chronic ␤-adrenergic stimulation with isoproterenol on the myocardial and systemic elaboration of TNF-␣, IL-1␤, and IL-6 in the rat.
Methods

Protocol and Tissue Harvest
All studies were performed in compliance with the NIH Guide for the Care and Use of Laboratory Animals (DHHS Publication No.
[NIH] 85-23, revised 1996). Male Wistar rats weighing 300 to 350 g were anesthetized with IM ketamine (30 mg/kg), acepromazine (1 mg/kg), and xylazine (6 mg/kg) before subcutaneous implantation of miniosmotic pumps (Alzet, model 2001;
) or saline (nϭ7). After anesthesia, measures of body weight, blood pressure, and heart rate (tail cuff, IITC Life Science model 29-SSP BP System), as well as tail venipuncture, were performed at baseline (1 week before pump implant). Measurements were also performed 3 and 7 days after implant. Serum was separated and stored at Ϫ80°C. On day 7, the heart was rapidly excised, rinsed in ice-cold physiological saline, and weighed. The atria were trimmed away, and the left and right ventricles separated and weighed. Tissue for mRNA expression and protein levels was snap frozen in liquid nitrogen and stored for not more than 3 days at Ϫ80°C before analyses. Part of the myocardium was embedded in OCT and snap frozen in liquid nitrogen for hematoxylin-eosin staining and immunohistochemistry (IHC).
Northern and Western Blotting
Total RNA isolation and Northern blotting, protein extraction and Western blotting, autoradiography, and densitometry were performed as previously described. 8, 9 For Northern blotting, the follow-ing cDNA (American Type Culture Collection) and oligonucleotide probes were used: hTNF-␣, mIL-1␤, mIL-6. h28S rRNA (40 base single stranded oligo; Oncogene Science) was used as an internal control, with results expressed as a ratio of the specific gene to the corresponding 28S rRNA. For Western blots, rabbit anti-rat IL-1␤, IL-6, and TNF-␣ antibodies (Biosource International) were used at a concentration of 3 (IL-1␤, TNF-␣) and 5 g/mL (IL-6). Prestained protein molecular weight standards (Broad range; Bio-Rad Labs) were run simultaneously with protein homogenates.
Localization of Proinflammatory Cytokines by IHC
Five-micrometer-thick cryosections were used for immunostaining using a commercially available kit (Vectastain ABC Elite Kit, Vector Laboratories). IHC was performed as described earlier. 9 Omission of primary antibody and rabbit preimmune serum in place of primary antibody served as controls. For IHC, rabbit anti-rat IL-1␤ and IL-6 (as described above) and anti-TNF-␣ antibodies (Serotec) were used at a concentration of 2 (TNF-␣) or 3 (IL-1␤, IL-6) g/mL. IHC staining intensity was evaluated in a blinded manner by light microscopy and graded on a semiquantitative scale from 0 to 3 (0 indicates none; 1, weak; 2, intermediate; 3, strong).
Serum Cytokine Levels
Serum TNF-␣ (sensitivity Ͻ0.7 ng/mL), IL-1␤ (sensitivity Ͻ3.0 pg/mL), and IL-6 (sensitivity Ͻ8.0 pg/mL) levels were measured by ELISA using commercially available kits (Biosource International). Studies were performed as per the manufacturer's instructions. Interpretation was done by an observer blinded to treatment group.
Statistical Analysis
Data shown are meanϮSD. Data were subjected to ANOVA with Student t test for significance. Correction for multiple comparisons were made using the Bonferroni factor. Probability values of 0.05 or less were considered significant.
Results
Effects of ␤-Adrenergic Stimulation on Hemodynamics and Heart Weights
Although isoproterenol did not affect systolic or diastolic blood pressure at either 3 or 7 days of treatment, heart rate increased significantly (Table 1) . Isoproterenol-treated animals exhibited significantly greater heart weights, as well as increased heart/body weight ratios at the time of euthanasia ( Table 2 ). Isoproterenol did not influence body weight over the 7 days of treatment (data not shown).
Histology and Histomorphometry
Hematoxylin-eosin staining was used to evaluate the extent of myocardial inflammation. Isoproterenol induced myocardial inflammatory cell infiltration, predominantly in the subendocardium. Mononuclear cell infiltrates ranged from isolated and focal in some areas to confluent in others. Inflammation was not observed in saline controls (data not shown).
␤-Adrenergic Stimulation Induces Proinflammatory Cytokine Expression
The results of Northern and Western blotting are shown in Figure 1 . In control myocardium, TNF-␣ and IL-1␤ were not detected, and IL-6 was only detected at low levels (densitometry; IHC revealed no positive immunoreactivity for either cytokine in control myocardium (Figure 2) . However, in isoproterenol-treated animals, all 3 cytokines were readily detected and were localized to the cytoplasm of myocardial cells and blood vessels in a diffuse manner (immunoreactivity scores: TNF-␣, 2.0Ϯ0.88; IL-1␤, 1.875Ϯ0.79; IL-6, 2.44Ϯ0.62; all PϽ0.05). Importantly, IHC staining was not noted in areas of inflammatory cell infiltration but rather in the myocardial tissue distinct from these areas.
In contrast, ELISA revealed no detectable amounts of either cytokine in serum in both saline and isoproterenoltreated animals at any timepoint.
Discussion
The results of this study demonstrate for the first time that chronic ␤-adrenergic stimulation with isoproterenol leads to myocardial gene expression and protein production of TNF-␣, IL-1 ␤, and IL-6. This appears to be a local effect, as there was no identifiable spillover of cytokines into the systemic circulation. The lack of systemic spillover is consistent with clinical studies that have indicated a lack of correlation between circulating TNF-␣ and norepinephrine levels in HF. 2 Additionally, our results confirm the findings of previous studies showing that isoproterenol promotes myocardial hypertrophy 10 while producing infarctlike lesions characterized by myocyte necrosis, myofibrillar degeneration, and leukocyte infiltration. 11 The pathogenesis of catecholamine-induced cardiac toxicity has yet to be fully defined. Mechanisms previously proposed include the following: myocardial necrosis and apoptosis, ischemia-reperfusion injury and free radical generation, and cAMP-dependent calcium overload of the cardiac myocyte. 1, 12 Whether ␤-adrenergic activation induces myocardial expression of TNF-␣, IL-1␤, and IL-6 directly via cAMP generation or indirectly via increased heart rate, myocardial ischemia, hypertrophy, free radical generation, or calcium overload is not clear. Regardless, the interplay between catecholamine stimulation and proinflammatory cytokines may have implications in regards to adverse chamber remodeling after myocardial injury. Our laboratory has recently shown that the salutary effects of ␤-adrenergic blockade on left ventricular dilation and hypertrophy after myocardial infarction were accompanied by selective reductions in myocardial expression of TNF-␣ and Il-1␤, 8 cytokines known to impair contractile function while promoting chamber enlargement. 3, 7 Thus, proinflammatory cytokines may play a significant role in the development of ␤-adrenergic cardiac toxicity.
Given that cytokines such as TNF-␣ can stimulate neutrophil migration, myocyte adherence, free radical production, and phagocytosis, we cannot determine from our study whether inflammatory cell infiltration is a cause or an effect of cytokine production. 13 However, TNF-␣, IL-1␤, and IL-6 immunoreactivity after isoproterenol was not confined to regions of inflammatory cell infiltration but rather found diffusely in myocardial tissue throughout the ventricle. This suggests either direct expression of cytokines by myocytes and blood vessels or paracrine effects. The lack of change in systemic blood pressure during isoproterenol infusion suggests that changes in wall stress per se did not play a major role in inducing myocardial cytokine expression. However, as we did not measure chamber size in this study, this cannot be excluded as a contributing factor.
In summary, our study confirms that constant ␤-adrenergic stimulation serves as a stimulus for local myocardial expression of TNF-␣, IL-1␤, and IL-6 unaccompanied by systemic elaboration. Although this was associated with myocardial inflammatory cell infiltration, generation of these cytokines occurs diffusely in myocardium, including areas remote from inflammation. Thus biological "cross-talk" exists between these 2 key neurohormonal systems in myocardium, and this interplay may play an important role in the pathogenesis of HF. Further studies need to be performed to delineate the mechanism of isoproterenol-induced myocardial proinflammatory cytokine gene expression.
